# CTNNB1-related disorders: clinical and radiological contributions from a French cohort

**Authors:** Eline Chauvet-Piat, Marie-Céline François-Heude, Gaël Manes, Arthur Coget, Nicolas Leboucq, Bérénice Lecardonnel, Heidy Baide-Mairena, Marine Allais, Souad Touati, Stéphanie Sanchez, Mirna Khalil, Hugues Chevassus, Marjolaines Willems, David Geneviève, Marion Serrand, Laure Mazzola, Vincent Dubard, Mathilde Renaud, Caroline Le Camus, Rebecca More, Mathieu Milh, Caroline Paris, Ians-Bouteiller Cécile, Agathe Roubertie

PMC · DOI: 10.3389/fneur.2026.1754143 · Frontiers in Neurology · 2026-02-18

## TL;DR

This study describes the clinical and radiological features of individuals with CTNNB1-related disorders, highlighting a complex motor phenotype and brain anomalies.

## Contribution

The study expands the known phenotypic spectrum of CTNNB1-related disorders through a detailed analysis of a French cohort.

## Key findings

- CTNNB1-related disorders are characterized by global developmental delay, microcephaly, and motor phenotypes including gait disturbances and hypertonia.
- Brain MRI findings include thickening of the anterior commissure, frontal lobe hypoplasia, and corpus callosum anomalies.
- Exaggerated startle reactions and sleep disturbances are common features in CTNNB1-related disorders.

## Abstract

CTNNB1 monoallelic pathogenic variants account for up to 4% of genetically determined cerebral palsy cases, yet their phenotypic spectrum remains poorly defined. We retrospectively analyzed 25 individuals with pathogenic CTNNB1 variants using medical records and a questionnaire. Data included genetic variants, perinatal history, developmental milestones, behavioral characteristics, head growth, feeding, sleep difficulties, neurological and ophthalmological assessments. Brain MRIs were reviewed by expert neuroradiologists. Twenty-two distinct heterozygous variants were identified. Microcephaly occurred in 16/22 patients. All exhibited global developmental delay, independent walking was achieved at a mean age of 2.1 years, with regression in 4/16 independent walkers. Behavioral disorders were frequent, as were oral sensorimotor disorders (21/25) and sleep disturbances (13/21). Lower limb hypertonia was present in 22/25 patients [spastic (8) and/or dystonic (11)]. Unstable gait were common among ambulatory patients. Exaggerated startle reactions, often since birth, were reported in 16/21. Exudative vitreoretinopathy was identified in 3/5 patients with retinal angiography. Brain MRI (19 patients) showed: thickening of anterior commissure (8), frontal lobe hypoplasia (9), widening of superior vermian sulci (10) and corpus callosum anomalies (7). This study broadens the spectrum of CTNNB1-related syndrome, reporting a complex motor phenotype combining (i) gait disturbances related to dystonic or non-dystonic hypertonia and unsteadiness, sometimes associated to dystonia in other body parts (ii) possible deterioration of motor achievements over the course of the disease (iii) an exaggerated startle reflex. New non-specific brain anomalies are precisely described. Our work underscores the need for registries and longitudinal studies to refine characterization and guide future therapies.

## Linked entities

- **Genes:** CTNNB1 (catenin beta 1) [NCBI Gene 1499]
- **Diseases:** cerebral palsy (MONDO:0006497), exudative vitreoretinopathy (MONDO:0019516)

## Full-text entities

- **Genes:** Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, GNAO1 (G protein subunit alpha o1) [NCBI Gene 2775] {aka DEE17, EIEE17, G-ALPHA-o, GNAO, HG1G, NEDIM}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}
- **Diseases:** epilepsy (MESH:D004827), Dystonia (MESH:D004421), Cerebral palsy (MESH:D002547), Hypermetropia (MESH:D006956), spastic (MESH:D009128), upper limb dysmetria (MESH:D002524), Axial hypotonia (MESH:D009123), startle (MESH:D016750), growth retardation (MESH:D006130), Lower limb hypertonia (MESH:D038061), patellar dislocation (MESH:D031222), autism spectrum disorder (MESH:D000067877), Intellectual disability (MESH:D008607), Frontal lobe hypoplasia (MESH:D001927), Sleep disturbances (MESH:D012893), Ataxia (MESH:D001259), optic nerve atrophy (MESH:D009896), Tyrosine Hydroxylase (TH) Deficiency (MESH:C537537), periventricular leukopathy (MESH:D054091), attention deficits (MESH:D001289), Behavioral disorders (MESH:D001523), vitreoretinopathy (MESH:D018630), hypertonia (MESH:D009122), Delayed language (MESH:D007805), schizophrenia (MESH:D012559), Exudative vitreoretinopathy (MESH:D000080345), anxiety (MESH:D001007), Head circumference (MESH:D006258), M-CF (MESH:D003550), Autistic traits (MESH:D001321), gait decline (MESH:D020234), Gestational diabetes (MESH:D016640), hemorrhage (MESH:D006470), falls (MESH:C537863), white matter abnormalities (MESH:D056784), Oral sensorimotor disorders (MESH:D020233), weight gain (MESH:D015430), aggressive behaviors (MESH:D010554), Microcephaly (MESH:D008831), feeding difficulties (MESH:D001068), Strabismus (MESH:D013285), fetal microcephaly (MESH:D005315), fatigue (MESH:D005221), Ophthalmological abnormalities (MESH:C536647), progressive peripheral spasticity (MESH:D010523), learning difficulties (MESH:D007859), syndromic atypical hyperekplexia (MESH:D000071017), abnormal retinal vascular development (MESH:D058456), impaired myelination (MESH:D020279), exaggerated (MESH:D000067251), developmental delay (MESH:D002658), Hyperactivity (MESH:D006948), refractive errors (MESH:D012030), Emotional dysregulation (MESH:D021081), retinal detachment (MESH:D012163), behavioral and sleep disturbances (MESH:D020187), motor impairment (MESH:D000068079), temper outbursts (MESH:C535300), Unstable gait (MESH:D000789), corpus callosum anomalies (MESH:D061085)
- **Chemicals:** melatonin (MESH:D008550), fluorescein (MESH:D019793)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Enterovirus C (no rank) [taxon 138950], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** p.(Arg661Ter), p.(Arg90Ter), c.936 + 1G > A, Thr298Arg, p.(Gln85Ter)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956669/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12956669/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12956669/full.md

---
Source: https://tomesphere.com/paper/PMC12956669